Skylar Ferrara, Ph.D.

Senior Scientist - R&D lead

Prodrug strategy for CNS-selective small molecule drugs


Publications


A CNS-targeting prodrug strategy for nuclear receptor modulators.


S. Ferrara, T. Scanlan

Journal of medicinal chemistry, 2020


Structure-Activity Relationships of Central Nervous System Penetration by Fatty Acid Amide Hydrolase (FAAH)-Targeted Thyromimetic Prodrugs.


J. M. Meinig, S. Ferrara, Tapas Banerji, Tania Banerji, Hannah Sanford-Crane, D. Bourdette, T. Scanlan

ACS medicinal chemistry letters, 2018


Targeting Fatty-Acid Amide Hydrolase with Prodrugs for CNS-Selective Therapy.


J. M. Meinig, S. Ferrara, Tania Banerji, T. Banerji, Hannah Sanford-Crane, D. Bourdette, T. Scanlan

ACS chemical neuroscience, 2017